Terms: = Liver cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Staging
7 results:
1. Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma.
Li Y; Wang C; Yin X; Jiang L; Li X; Yang J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14879-14888. PubMed ID: 37599316
[TBL] [Abstract] [Full Text] [Related]
2. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
3. [Combination Chemotherapy Including Intraperitoneal(IP)Administration of Paclitaxel(PTX)followed by PTX, CDDP and S-1Triplet Chemotherapy for CY1P0 Gastric cancer].
Shinkai M; Imano M; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Kimura Y; Imamoto H; Furukawa H; Yasuda T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1355-1357. PubMed ID: 29394632
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
[TBL] [Abstract] [Full Text] [Related]
5. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
[TBL] [Abstract] [Full Text] [Related]
6. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic sdhb-associated pheochromocytoma and paraganglioma.
Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
[TBL] [Abstract] [Full Text] [Related]
7. [Side effects and anti-cancer effects following intraperitoneal (ip) administration of mitomycin C (MMC)].
Takizawa K; Ino Y; Isono T; Sato M; Iguchi T; Takeda Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1877-83. PubMed ID: 3109329
[TBL] [Abstract] [Full Text] [Related]
